Skip to content
Recall Observatory FDA recall evidence

Drug product

Meloxicam Tablets, USP, 15 mg, 1000 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., Kurkumbh, India; Manufactured for: Cipla USA, Inc., 9100 S. Dadeland Blvd., Suite 1500 Miami, FL 33156. NDC: 69097-159-15

D-0190-2024

January 26, 2022

Class II

Product summary

Firm
CARDINAL HEALTHCARE
Event
Event 89450
Status
Terminated
Classification
Class II
Quantity
1 unit
Official record key
drug-enforcement:D-0190-2024

Official wording

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Code information: Batch KA11489

Distribution pattern: Nationwide USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations